Photodynamic diagnostic of superficial bladder carcinoma;Photodynamische diagnostik des harnblasenkarzinoms

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 44, 2007, Pages 2332-2335

  Denzinger, Stefan ^a   Rossler W ^a   Otto, W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 aminolevulinic acid; Bladder carcinoma; Cost analysis; Photodynamic diagnostic; Recurrence rate

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN; PHOTOSENSITIZING AGENT;

BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GROWTH; DIAGNOSTIC PROCEDURE; HUMAN; PHOTODYNAMICS; PROGNOSIS; REVIEW; SUPERFICIAL CANCER; ARTICLE; BLADDER TUMOR; GERMANY; INTRAVESICAL DRUG ADMINISTRATION; LENGTH OF STAY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INTRAVESICAL; AMINOLEVULINIC ACID; GERMANY; HUMANS; LENGTH OF STAY; PHOTOSENSITIZING AGENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 36048968090     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-991653     Document Type: Review

References (15)

1. Burger M, Zaak D, Stief CG et al. Photodynamic Diagnostics and Noninvasive Bladder Cancer: Is It Cost-Effective in Long-Term Application? Eur Urol 2007; 52: 142-147
2. Daniltchenko DI, Riedl CR, Sachs MD et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005; 174: 2129-2133
3. Denzinger S, Burger M, Walter B et al. Clinically relevant reduction in the risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of a prospective randomized study. Eur Urol 2007; 69: 675-679
4. D'Hallewin MA, Bezdetnaya L, Guillemin F. Fluorescence Detection of Bladder Cancer: A Review. Eur Urol 2002; 42: 417-425
5. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Rößler W. Senkung des Rezidivrisikos oberflächlicher Harnblasenkarzinome mittels 5-Aminolävulinsäure-induzierter Fluoreszenzdiagnostik. Urologe (A) 2003; 42: 1366-1373
6. Grimbergen MCM, van Swol CFP, Jonges TGN, Boon TA, van Moorselaar RJA. Reduced Specificity of 5-ALA Induced Fluorescence in Photodynamic Diagnosis of Transitional Cell Carcinoma after Previous Intravesical Therapy. Eur Urol 2003; 44: 51-56
7. Hungerhuber E, Stepp H, Kriegmair M et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007; 69: 260-264
8. Jain S, Kockelbergh RC. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer. BJU International 2005; 96: 17-21
9. Jichlinski P, Leisinger HJ. Fluorescence Cystoscopy in the Management of Bladder Cancer: A Help for the Urologist! Urol Int 2005; 74: 97-101
10. Jocham D, Witjes F, Wagner S. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005; 174: 862-866
11. Riedl CR, Daniltschenko D, Koenig F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-Aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001; 165: 1121-1123
12. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171: 135-138
13. Zaak D, Hofstetter A. The Current Diagnosis of Superficial Bladder Cancer Must Be Reconsidered. Urol Int 2002; 69: 85-90
14. Zaak D. Your patient with carcinoma of the urinary bladder. Options for organ preservation. MMW Fortschr Med 2003; 145: 28-32
15. Zaak D, Karl A, Knüchel R et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU International 2005; 96: 217-222